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Abstract 
Aim: To determine the prognostic value of cardiopulmonary exercise testing (CPET) for 
major vascular surgery in South African patients. 
Methods: CPET has been used in Durban since October 2004 to predict cardiac risk for 
high-risk patients undergoing major vascular surgery. A submaximal 'anaerobic threshold' 
(AT) test was conducted on all high-risk patients. Patients were classified into two groups: 
'low AT' where the oxygen consumption at the AT was <1 lml.kg^.min"1 for cycling or 
< 9ml.kg"1.mkf1 for arm cranking and 'high AT' when the patient surpassed these targets. 
Analysis of all in-hospital deaths following surgery was conducted by two independent 
assessors blinded to the CPET test result. Deaths classified as primarily 'cardiac in origin' 
have been used in this retrospective cohort analysis. 
Results: The AT measured during CPET was not a statistically significant pre-operative 
prognostic marker of cardiac mortality. However, the survivors of the patients with a 'low 
AT' may be identified by their response to increasing metabolic demand between 5 and 7 
ml.kg^.min"1. Survivors were more dependent on increasing heart rate, while non-survivors 
were more dependent on oxygen extraction. When this information is added to the AT, 
CPET was the only test statistically associated with cardiac mortality, in comparison to 
Lee's Revised Cardiac Risk Index and the resting left ventricular ejection fraction which 
were not statistically associated with cardiac death. A hundred percent of patients with a 
positive test died of cardiac causes, while 11% of the patients with a negative test had 
cardiac deaths. The risk ratio associated with cardiac death following a positive test was 
8.00 [95% CI 3.8-16.9]. The sensitivity was 0.25 [95% CI 0.04-0.64], the specificity was 
1.00 [95% CI 0.90-1.00], the positive predictive value was 1.00 [95% CI 0.20-0.95] and 
the negative predictive value was 0.88 [95% CI 0.74-0.95]. 
v 
Conclusions: CPET provides valuable prognostic information in our surgical population. 
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Although in the non-surgical population Human Immunodeficiency Virus (HIV) and 
Acquired Immunodeficiency Syndrome (AIDS) is now probably the leading cause of 
morbidity and mortality in South Africa (Dougan, 2005, Bradshaw et al., 2005), it has not 
had the same impact on peri-operative morbidity and mortality in South Africa (Cacala et 
al., 2006). 
Cardiovascular complications are an important cause of morbidity and mortality following 
major surgery in the developed world (Devereaux et al., 2005c). Major cardiovascular 
complications following abdominal aortic surgery have an incidence of over 20% 
(Nishimori et al., 2006). Myocardial infarction within 30 days of elective aortic aneurysm 
repairs was reported in 7% of the cases in the United Kingdom's recent National 
Confidential Enquiry into Perioperative Deaths (NCEPOD, 2005). Peri-operative 
myocardial infarction is associated with an increased risk of in-hospital mortality 
(Devereaux et al., 2005b) which is borne out in the NCEPOD study where 45% of the 
patients who sustained a peri-operative myocardial infarct died within 30 days of surgery 
(NCEPOD, 2005). Peri-operative ischaemia and myocardial infarction (MI) also decrease 
longterm survival (Devereaux et al., 2005b) and significantly increases consumption of 
health resources (Devereaux et al., 2005c). It is likely that major cardiovascular 
complications are the leading cause of peri-operative mortality in South Africa as well, 
although there is unfortunately no literature to confirm this statement. However, the 
subsequent discussion will add credence to this statement. 
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There is no consensus on which special investigation is preferable in pre-operative cardiac 
risk assessment (Auerbach and Goldman, 2006, Eagle et al., 2002). However, a test of 
dynamic function is preferable, in comparison to a test of static ventricular function (Kertai 
et al, 2003). Theoretically, an ideal test would assess both ventricular function and 
myocardial ischaemia. In addition, an ideal test should allow for risk stratification based on 
whether limitation is secondary to ventricular function, myocardial ischaemia or both. 
Cardiopulmonary exercise testing (CPET) has the capacity to separate these physiological 
determinants of peri-operative outcome (Older et al., 1993, Older et al., 1999). In addition, 
CPET allows for determination of limited physical performance by analysis of the various 
physiological markers of oxygen delivery (Wasserman et al., 2005). 
The aim of this study was to conduct a retrospective analysis of the use of CPET at Inkosi 
Albert Luthuli Central Hospital (I ALCH) and to compare the prognostic value of CPET 
with other pre-operative indicators of cardiac mortality. 
2 
Chapter 2 
Peri-operative cardiac risk 
2.1. Determinants of peri-operative cardiovascular risk 
2.1.1. Clinical risk indices 
The original index of peri-operative cardiovascular risk was described by Goldman 
(Goldman et al., 1977), with subsequent modification (Detsky et al., 1986). The recent 
publication of Lee's Revised Cardiac Risk Index (RCRI) (Lee et al., 1999) has been found 
to be significantly better than previous risk indices at predicting cardiovascular 
complications (Gilbert et al., 2000) and it has also been validated outside of its derivation 
population (Boersma et al., 2005). (Table 2.1) The predictive power of Lee's RCRI could 
be further improved by including age and more specific characteristics of surgical risk 
(Boersma et al., 2005). 
Table 2.1 Cardiovascular outcomes associated with Lee's Revised Cardiac Risk Index 
Number of CVS risk factors Major CVS complications Cardiovascular death 
(95% CI) 
(Lee et al., 1999) (Boersma et al., 2005) 
0 0.5% (0.2-1.1) 
1 1.3% (0.7-2.1) 0.3% 
2 3.6% (2.1-5.6) 0.7% 
>3 9.1 % (5.5-13.8) 1.7% 
4 3.6 % 
CVS: (cardiovascular). Clinical risk factors include high-risk surgery, ischaemic heart 
disease, history of congestive cardiac failure, history of cerebrovascular disease, insulin 
therapy for diabetes, and a preoperative serum creatinine of >177umol/L (Lee et al., 1999) 
Although, Lee's RCRI and Kertai's revised customised probability index had similar 
predictive values for the derivation and validation cohorts (Lee et al, 1999, Kertai et al., 
2005), this is not surprising as the populations from which these risk indices were derived 
and then validated were the same. Thus, there is a fundamental flaw in believing that these 
3 
clinical risk indices will be of similar prognostic value in South Africa, as these risk 
indices were derived and/or validated in North American and European patients. For these 
risk indices to be applicable in South Africa they would have to fulfil two criteria. Firstly, 
South Africans should be of similar cardiovascular risk to North American and European 
patients. Secondly, the 'weighting' of the clinical risk factors associated with peri-
operative cardiovascular complications needs to be similar to that reported in the 
international literature. Unfortunately neither of these criteria are met, and thus the 
applicability of Lee's RCRI (Lee et al., 1999) in South Africa is therefore contentious. 
Indeed, it appears that South Africans are now at higher cardiovascular risk than North 
American and European populations. A process of epidemiological transition has been 
described to illustrate the progression of cardiovascular risk in a population (Opie and 
Mayosi, 2005). Exposure to 'Western civilisation' is integral to increasing cardiovascular 
risk. This may be first identified by a deviation from a steady blood pressure despite 
increasing age, to one of an increasing blood pressure associated with increasing age (Opie 
and Mayosi, 2005). Indeed, the lack of an increase in blood pressure with age has been 
shown in isolated socio-economic groups including Khoisan people and early East African 
tribal groups. Cardiovascular disease is now the leading cause of death in all developing 
countries, with the exception of sub-Saharan Africa, where it is displaced by HIV/AIDS 
(Opie and Mayosi, 2005). The process of epidemiological transition with respect to 
cardiovascular disease from these healthy isolated tribal units is first characterised by a 
transition phase associated with disease and famine. However, as pandemics decrease, 
cardiovascular disease increases, followed by a phase of degenerative and man-made 
disease with cardiovascular disease being prominent, (Opie and Mayosi, 2005) and finally 
(possibly) a phase of a partial decrease in risk with health awareness and appropriate 
4 
surveillance and management of cardiovascular risk factors. South Africans are probably 
now at the point of degenerative and man-made cardiovascular disease, while developed 
countries (from which these clinical risk indices are derived) are probably now in the phase 
of decreasing cardiovascular risk associated with health awareness and surveillance. South 
Africans must therefore be considered to be at a higher cardiovascular risk than what the 
published clinical risk indices predict (Lee et al., 1999, Kertai et al., 2005). This process of 
epidemiological transition would also suggest that within South Africa the various 
population groups comprising our population are potentially at different phases of 
cardiovascular risk, due to differences in socio-economic status (Steyn et al., 2005). 
It also appears that the risk factors associated with myocardial infarction in South Africans 
are not necessarily the same as that of the North American and European populations. Five 
risk factors in the INTERHEART study were shown to be associated with first-time acute 
myocardial infarction (AMI) in sub-Saharan Africans. These include a history of smoking, 
diabetes, and hypertension, abdominal obesity and the ratio of apolipoprotein B to 
apolipoprotein A-l (Steyn et al., 2005). These five risk factors can account for 89.2% for 
the risk of MI (Steyn et al., 2005). 
Hypertension and diabetes were significantly more important risk factors for AMI in the 
African INTERHEART study in comparison to the global INTERHEART study (odds 
ratio (OR) 3.44 versus 2.49 and OR 3.55 versus 3.07 respectively). Abdominal obesity is 
also a significantly stronger risk factor in the African INTERHEART study than the global 
study. Smoking status and permanent stress are also significant predictors of AMI in the 
African group. Indeed as the OR of a number of these risk factors is higher than that of the 
overall INTERHEART study, the cardiovascular burden in Africa may well be larger, due 
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to uncontrolled/ undiagnosed/ poorly managed major cardiovascular risk factors (Steyn et 
al., 2005), (which is what we would expect from our understanding of epidemiological 
transition) (Opie and Mayosi, 2005). 
Although these risk factors appear to be consistent across ethnic groups in sub-Saharan 
Africa; the following differences are noted when looking at black, coloured and European/ 
or other ethnic groups. Hypertension and abdominal obesity in black Africans result in a 
significantly higher risk of AMI than the overall INTERHEART results (Steyn et al., 
2005). Black Africans have a significantly higher risk associated with hypertension and a 
lower risk associated with current smoking or atherogenic lipid profile (Steyn et al., 2005). 
The risk of AMI increases in black Africans with higher income and education (Steyn et 
al., 2005). This is higher than white patients of a high income bracket, probably again as a 
result of epidemiological transition (Opie and Mayosi, 2005). Currently, high income black 
South Africans are probably in the phase of degenerative and man-made disease (Opie and 
Mayosi, 2005) while high income white South Africans are in a phase of increased health 
awareness and surveillance. The history of stroke suggests a particularly high risk group of 
black South Africans (Joubert et al., 2000). 
In South African Asian Indians, the older patients (>65 years) frequently have 
hypertension, diabetes and a history of coronary artery disease as risk factors for acute 
coronary disease. Younger patients (<45 years) however present with a stronger smoking 
history and obesity, and a familial history of vascular disease as risk factors for acute 
coronary syndrome. All groups had associated elevated cholesterol levels as a risk factor 
(Ranjith et al., 2005), in contrast to black South Africans (Steyn et al., 2005). 
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Sub-Saharan individuals of European / other African descent have a lower cardiovascular 
risk associated with the tertiary education and the highest income group (Steyn et al., 
2005), suggesting increased surveillance and management of cardiovascular risk factor 
(Opie and Mayosi, 2005). 
The variance of risk factors associated with myocardial infarction between Sub-Saharan 
Africans and the globally accepted risk factors, and the inter-ethnic differences in risk 
factors, suggest that the clinical risk indices of peri-operative cardiovascular risk that are 
not derived in South Africa, are probably of limited value to South Africans. 
2.7.2 Surgical risk 
The type of operation is a strong determinant of cardiovascular risk. This has been 
highlighted in Lee's RCRI (Lee et al., 1999), where high-risk surgery included 
intraperitoneal, intrathoracic and supra-inguinal vascular surgery. Vascular surgical 
patients have the highest prevalence of cardiovascular disease in the noncardiac surgical 
population, and hence it is this group that is often investigated when studying peri-
operative cardiovascular risk. When further classifying vascular surgical procedures, 
Kertai et al have improved the predictive power of the RCRI (Kertai et al., 2005, Lee et al., 
1999). They defined the following risk groups in vascular surgical patients: High-risk 
(ruptured abdominal aortic aneurysm), high-intermediate risk (thoraco-abdominal and 
abdominal aortic surgery), low-intermediate risk (infra-inguinal bypass) and low risk 
(carotid endarterectomy) (Kertai et al., 2005). In addition, they also considered concurrent 
medications (beta-blockers and statins) which may be cardioprotective in the peri-operative 
period. The development of the subsequent customised probability model improved the 
positive predictive value of the original Lee model (Kertai et al., 2005). 
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2.1.3. Functional capacity and aerobic metabolic capacity 
Major surgery has been equated to a physical endurance event (Biccard, 2005). Surgery 
initiates a postoperative stress response of approximately 48 to 72 hours in duration 
(Davies and Wilson, 2004), which is associated with an increase in oxygen consumption 
and metabolic rate (Older and Smith, 1988, Davies and Wilson, 2004). Hence the aerobic 
metabolic capacity of an individual is of fundamental importance in determining 
postoperative survival. The similarity between the surgical stress response and endurance 
exercise, is that the aerobic capacity an individual can sustain decreases with time. Thus 
the aerobic work measured in the same individual over a shorter duration of time is higher 
than that recorded during endurance exercise or following major surgery (Biccard, 2004). 
The discrepancy between the analogy of endurance exercise and the postoperative surgical 
stress response is firstly that a poor functional capacity assessment is not necessary 
secondary to poor aerobic function, but rather a function of comorbidity (Biccard, 2005, 
Reilly et al., 1999) and secondly, the oxygen extraction ratio decreases postoperatively 
(Older and Smith, 1988, Davies and Wilson, 2004), while it increases with exercise 
(Wasserman et al., 2005). 
The aetiology of peri-operative cardiovascular complications is multifactorial. Patients 
have been found to have fatal myocardial infarctions both at the site of critical lesions and 
at noncritical sites not traditionally associated with myocardial infarction (Dawood et al., 
1996, Cohen and Aretz, 1999). It is this latter group that is almost certainly a consequence 
of the prolonged postoperative increase in myocardial oxygen demand (Le Manach et al., 
2005). The surgical stress response is associated with an increase in oxygen demand from 
110 to 170 ml.min" m" (5 ml.kg" .min") postoperatively, which is equivalent to 1.4 
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metabolic equivalents (METs) (Davies and Wilson, 2004, Older and Smith, 1988). A MET 
is the basal metabolic rate assumed to be equivalent to an oxygen consumption of 3.5 
ml.kg"\min"1 (Eagle et al., 2002). Metabolic rates as high as 7 ml.kg"1 .min"1 (240 ml.kg" 
l.m2) (or 2 METS) have been recorded postoperatively (Older et al., 1993, Older and 
Smith, 1988, Shoemaker et al., 1988). 
Another important recent development is the increasing importance of heart failure as an 
adverse peri-operative predictor (Hernandez et al., 2004). Although heart failure has 
always been an adverse peri-operative prognostic marker (Goldman et al., 1977, Detsky et 
al., 1986, Lee et al., 1999), it has only recently been shown to be a significantly more 
important risk factor than coronary artery disease in predicting death within 30 days of 
major noncardiac surgery (Hernandez et al., 2004). 
The pre-operative assessment of functional capacity is therefore an important determinant 
of both coronary and cardiovascular failure risk. Peri-operative cardiac risk is significantly 
increased if a patient is unable to function at 4 METs (Eagle et al., 2002). In patients over 
60 years of age undergoing major abdominal surgery, an anaerobic threshold (AT) 
measured during cardiopulmonary exercise testing of less than 11 ml.kg"1 .min"1 was found 
to be an independent predictor of peri-operative mortality (Older et al., 1993). A pre-
operative AT above 14 ml.kg"1.min"1 was associated with a good outcome (Older et al., 
1993) which is equivalent to approximately 4 METs. Importantly, all the patients in this 
study underwent high or intermediate risk surgery as classified by the American College of 
Cardiology/ American Heart Association (ACC/AHA) algorithm (Eagle et al., 2002). 
(Table 2.2) Myocardial ischaemia in patients with poor functional capacity (Older et al., 
1993) (Table 2.3) or symptoms of ischaemia limiting functional capacity (Reilly et al., 
9 
1999), significantly increased adverse peri-operative cardiac events during major or 
intermediate risk surgery. It is the patients with positive Lee's Revised Cardiac Index risk 
factors who are most likely to have peri-operative myocardial ischaemia (Lee et al., 1999). 
Table 2.2. Peri-operative mortality and anaerobic threshold (Older et al., 1999, Older 
e^ , . J^9^iccard 1 2005i___ _ _ _ _ _ _ _ _ _ _ _ _ _ _ , , _ _ _ _ , _ , _ _ 
First author (year) AT < 11 ml.kg" .min" AT > 11 ml.kg" .min" Risk ratio 
(95% CI) 
Older et al (1993) 18 °„ (10 of 55 patients) 0.8 ",,(1 of 132 patients) 24(3.1-183) 
AT anaerobic threshold 
Table 2.3. Peri-operative cardiovascular mortality associated with the anaerobic 
threshold in patients undergoing major abdominal surgery (Older et al.. 1993) 
\ l II nil.kg'.min"1 AT • II ml.kg'.min ' 
JV^ischaejmiaJ%)__ _ _ _ _42_ _ _ _ . . _ _ . . _ . _ i _ _ „ , _ 
AT anaerobic threshold 
Stair climbing capacity also has peri-operative prognostic importance, where the inability 
to climb two flights of stairs is a predictor of serious peri-operative complications (Reilly 
et al., 1999, Girish et al., 2001). Climbing a flight of stairs is a 5.5 METs equivalent 
according to the Duke Activity Status Index (Hlatky et al., 1989) and thus these findings 
are in agreement with the original work on pre-operative AT testing (Older et al., 1993). 
However, unlike the AT, the inability to climb two flights of stairs is not a predictor of 
increased risk of peri-operative mortality (Biccard, 2005). (Table 2.4) This confirms the 
reservations of using the Duke Activity Status Index in the peri-operative period, which 
has never been evaluated in the peri-operative setting (Ridley, 2003). 
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Table 2.4. Peri-operative mortality in all major noncardiac surgery associated with 
flights ofstairs climbed (Biccard, 2005) „ _ „ _ _ 
Number of flights Fatalities Survivors 
> 2 flights 4 332 
42flighte_ _ _ _ _ _ _ _ _ _ . . . 2 _ _ _ _ _ _ _ _ _ J 5 7 _ _ _ _ 
Risk ratio (95% CI) 0.47 (0X&2.5) 
This discrepancy between the prognostic power of stair climbing and the AT is probably 
related to the metabolic pathways measured with each test. Two factors have limited the 
ability of pre-operative field tests of functional capacity to accurately predict postoperative 
complications secondary to poor aerobic capacity. Firstly, some tests have been of too 
short a duration and thus measure the oxygen-independent metabolism characteristic on 
initiation of exercise, as opposed to oxidative phosphorylation which takes a few minutes 
before it becomes dominant (Biccard, 2005). This is further aggravated by the delay in 
V02-on-kinetics of patients with heart failure, pulmonary and peripheral vascular disease 
(Biccard, 2005, Grassi, 2000, Grassi, 2001, Hughson et al., 2001), which are clinical 
conditions commonly associated with patients requiring pre-operative assessment of 
functional capacity. Secondly, there is an inconsistent relationship between the anaerobic 
threshold and the peak oxygen consumption (V02peak) (Biccard, 2005) and the majority of 
field tests estimate the V02peak and not the anaerobic threshold. It is the anaerobic threshold 
however which has been shown to be a more sensitive predictor of outcome in patients 
with heart failure than the V02peak (Gitt et al., 2002). 
A pre-operative functional capacity should therefore allow for V02-on-kinetics and 
accurately measure aerobic or oxygen-dependent metabolism. Anaerobic threshold testing 
measured during cardiopulmonary exercise testing meets these requirements. Three 
minutes of unloaded exercise at the beginning of the test,(York, 2005) should allow 
adequate time for VC^-on-kinetics (Hughson et al., 2001) even in patients with heart 
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failure, pulmonary and peripheral vascular disease(Grassi, 2001). The measurement of the 
AT is a marker of the point at which there is increased flux of pyruvate to lactate resulting 
in an imbalance of production and removal lactate from the circulation, with increased 
exercise intensity (Biccard, 2005, Wasserman et al., 2005). The result is an increased 
reliance on oxygen-independent metabolism to supplement exercise performance above the 
AT (Wasserman et al., 2005). Work up to the AT is predominantly oxygen-dependent in 
incremental work, and thus of prognostic value in patients dependent on aerobic metabolic 
performance (Older et al., 1993, Older et al., 1999, Gitt et al, 2002). 
The AT measured during CPET reflects aerobic metabolic capacity, while stair climbing 
reflects both aerobic and anaerobic metabolic pathways, and thus stair climbing 
performance is a closer estimate of V02peak than AT, thus overestimating the aerobic 
functional capacity necessary to sustain the peri-operative stress response (Biccard, 2005). 
Conversely, weight bearing may lead to underperformance during stair climbing (Biccard, 
2005). Thus stair climbing may incorrectly classify patients as either good or poor 
functional capacity, decreasing its prognostic performance (Biccard, 2005). 
The inability to walk four blocks or more is used as a screening test of exercise capacity 
(Reilly et al., 1999). Patients unable to exercise, especially in patients without 
cardiopulmonary exercise limitation results in the poor positive predictive power of 
exercise capacity as a screening tool for pre-operative evaluation (Auerbach and Goldman, 
2006). 
Although approximately 4 METs of pre-operative aerobic metabolic capacity is necessary 
to predict postoperative survival (Older et al., 1993, Older et al., 1999) (which probably 
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never requires more than 2 METs) (Davies and Wilson, 2004), some patients still survive 
major surgery even if 4 METs is not achieved aerobically pre-operatively (Table 2.2). 
There has been no attempt to identify the physiological determinants that identify this 
group of patients. Patients with a poor aerobic capacity do not have the ability to increase 
oxygen extraction postoperatively. Although, elderly patients have an oxygen extraction 
ratio of approximately 50% when working near the AT (Weber and Janicki, 1985), 
postoperatively the oxygen extraction ratio falls to about 30%, meaning that the cardiac 
output has to rise further to compensate for the decrease in oxygen extraction (Older et al., 
1993). This would result in the cardiac output measured at 1.4 METs postoperatively, 
exceeding the cardiac output at the same metabolic rate and in the same patient recorded 
during exercise testing pre-operatively. This suggests that in this group of patients with a 
limited aerobic capacity, there is a subset of patients with the capacity to increase oxygen 
delivery (DO2) in the postoperative period, as we know they cannot compensate for the 
increased oxygen consumption (VO2) by increasing oxygen extraction. 
D02 = CO x CaC02 1 
D02 = (HR x SV) x (Hb x Huffner's constant x Sa02) 2 
Where CO = cardiac output 
CaC02 = oxygen carrying capacity 
DO2 = oxygen delivery 
HR = heart rate 
SV = stroke volume 
Hb = haemoglobin concentration 
13 
SaC>2 = Haemoglobin oxygen saturation 
Assuming that high-risk surgical patients are appropriately managed postoperatively, then 
haemoglobin and oxygen saturation should be adequate. The result is that in order to 
increase the DO2 postoperatively, the patient is dependent on the ability to increase the 
cardiac output. Cardiac output increases by increasing stroke volume and heart rate up to 
40% maximal oxygen consumption (V02peak), and then any further increase in cardiac 
output is a function of the heart rate (Astrand et al., 1964). It is possible that patients with a 
poor pre-operatively aerobic capacity who survive the surgical stress response have an 
aerobic heart rate reserve, hereafter referred to as a 'aerobic surgical heart rate reserve', 
while non-survivors have no or minimal 'aerobic surgical heart rate reserve'. It is possible 
that if there is a necessity for a further increase in DO2 postoperatively (for example 
secondary to acute haemorrhage or infection) patients who can further increase their 
cardiac output by a further increase in heart rate, while maintaining aerobic metabolism, 
may be the group constituting the survivors. Due to the nature of CPET, it may be possible 
to identify this group when analysing the pre-operative test results. 
In non-surgical heart failure patients, CPET markers other than the AT or V02peak have had 
prognostic importance in predicting long term survival. These have included cardiac power 
(systolic arterial pressure x V02peak) (Cohen-Solal et al., 2002), or (mean arterial pressure x 
VChpeak) (Williams et al., 2001). However, the V02peak is a marker of both aerobic and 
oxygen-independent work, whereas the surgical stress response is dependent on aerobic 
metabolic demand and hence the evaluation of an aerobic marker such as the AT may be 
more appropriate (Biccard, 2005). In addition, the AT has recently been shown to more 
predictive of survival in non-surgical heart failure patients than the V02peak (Gitt et al., 
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2002). Importantly, the safety of measuring the AT is that it is a submaximal test in 
comparison to the V02peak (Biccard, 2005). In summary, it would appear inappropriate to 
evaluate these markers of maximal circulatory power in surgical patients at present. It may 
be more appropriate to evaluate mechanisms of increasing DO2 at metabolic rates 
commensurate with the stress response of the postoperative period. 
2.2. Pre-operative investigation for the high-risk surgical patient 
2.2.1. Statistical principles and Bayesian theory of pre-operative investigation 
Pre-operative investigation is undertaken when patients of indeterminate cardiovascular 
risk present for surgery, that is, they are not in an obviously low or high-risk group. One 
can increase the prevalence of a condition (or outcome) in the population being studied by 
sequential screening and thus combining tests. The post-test prevalence thus becomes the 
pretest prevalence for a subsequent test (Ridley, 2003). Sequential screening is the basis of 
clinical management algorithms (Ridley, 2003). By sequential investigation, the prevalence 
of an uncommon disease may be increased (Ridley, 2003). This is the principle of 
application of Bayesian theory, where the pre-test probability of an event is further 
modified by associated clinical risk indices and subsequent findings on pre-operative 
investigation (Goldman, 1996). It is this subsequent result which is most likely to result in 
a change in practice or management. Although a number of pre-operative investigations 
have been reported in the literature, an understanding of the limitations (and strengths) of 
the statistical methods used is essential in interpreting their clinical importance. 
The commonly reported statistical terms associated with pre-operative investigation 
include sensitivity, specificity, positive and negative predictive value and likelihood ratios. 
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The definitions (Table 2.5) and the advantages/ disadvantages of these statistical terms 
(Table 2.6) are tabulated. 
Table 2.5. Definition of statistical terms (Ridley, 2003, Coetzee, 2004) 
Positive Negative 
Sensitivity / specificity TP / TP + FN TN / TN + FP 
PPV/NPV (TP/TP + FP)xl00 (TN/TN + FN)xl00 
Likelihood ratio Sensitivity / (1 - specificity) (1 - sensitivity) / specificity 
TP true positive; TN true negative; FP false negative; FN false positive; PPV positive 
predictive value; NPV negative predictive value 
Table 2.6. Advantages and disadvantages of statistical terms (Ridley, 2003, Coetzee, 
2004) 
Statistical terms Advantages Disadvantages 
Sensitivity / Independent of disease prevalence Assumes the disease status of 
specificity the patients is known 
PPV / NPV Calculates the post-test probability PPV markedly affected by the 
Disease status need not be known prevalence of the disease in the 
population 
Likelihood Independent of disease prevalence Post-test probabilities require 
ratios Independent of pre-test probabilities large ratios 
PPV positive predictive value; NPV negative predictive value 
Considering the limitations of these statistical terms is necessary if one is to compare our 
local findings with reports in the international literature. While the advantage of the 
sensitivity and specificity is that they are not influenced by the pre-test prevalence or pre-
test probability (Ridley, 2003), the disadvantage of using the sensitivity and specificity to 
describe findings is that they may not be reproducible when populations are not matched 
(Ridley, 2003). This would be an important consideration in comparing our findings in 
South African vascular surgical patients, to other vascular patients reported in the 
international literature. 
Similarly, the use of predictive values has limitations. The pre-test prevalence is the 
prevalence of the disease prior to performing the investigation (Ridley, 2003). The post-
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test prevalence is the likelihood of the patient still having the disease after the test has been 
performed (Ridley, 2003). This revised pre-test prevalence is known as the positive 
predictive value or negative predictive value (Ridley, 2003). The advantage of the 
predictive values is that the denominator is a function of the test results, and not the 
prevalence of the disease in the population (as is the case with the sensitivity and 
specificity) (Ridley, 2003) and hence this may be clinically useful. However, the predictive 
values are influenced by the prevalence of the disease in the population being tested 
(Ridley, 2003). For example, if a test has a sensitivity and specificity of 95%, only when 
the prevalence of the event in the population is 20%, is the PPV > 80% (Ridley, 2003). 
The likelihood ratio (LR) as an alternative statistical analysis of a pre-operative test is 
clinically useful for a number of reasons. Firstly, it is independent of the population 
prevalence(Coetzee, 2004). Likelihood ratio is either the probability of a diseased person 
having an event (positive) or not having event (negative) compared to a non-diseased 
person with the same test result (Coetzee, 2004). Secondly, it can be used with a prior 
probability (or prevalence) to create a posterior probability for the patient being 
investigated, which would further influence clinical management (Beattie et al., 2006, 
Fagan, 1975). Thirdly, it allows for the use of continuous data (and not necessarily 
dichomotous as in the previous statistical definitions) (Grimes and Schulz, 2005). 
2.2.2. The statistical performance of clinical risk indices and special 
investigations in predicting peri-operative major cardiac complications 
Tabulation of the current evidence concerning clinical risk indices and pre-operative 
investigations generally shows a high specificity and a low sensitivity.(Table 2.7) 
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ECG electrocardiogaphy; echo echocardiography; f All complications during hospitalisation; $ All 
cause mortality; | Vascular surgical patients; * In hospital CVS mortality; ** 30 day CVS 
mortality or myocardial infarction 
a (Ridley, 2003), b (Auerbach and Goldman, 2006), c (Reilly et al., 1999), d (Biccard, 2005), e 
(Kertai et al, 2003), f (Chassot et al., 2002), g (Eagle et al., 2002), h (Beattie et al., 2006), i (Older 
et al., 1993), j (Older et al., 1999) 
If likelihood ratios are calculated and a likelihood ratio of <0.2 (for a negative LR) and >5 
(for a positive LR) is considered acceptable performance (Coetzee, 2004), then only 6 
results are clinically useful (Table 2.8), and probably in reality only four, as the high risk 
Goldman (Goldman et al., 1977) and Detsky (Detsky et al., 1986) groups are probably 
identified routinely today in the 'Major clinical predictors' group of the ACC/AHA 
algorithm (Eagle et al., 2002). Unfortunately, all these tests only exhibit high specificity 
(the ability to predict true negatives), as opposed to a high sensitivity (which is the ability 
to predict true positives). 
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Table 2.8. Clinically useful pre-operative risk indices or investigations based on 
reported likelihood ratios 
Clinical risk index or Pre-operative investigation Criterion „_____. 
Goldman's Risk Index 
Detsky Modified Risk Index 
Lee's RCRI 
Dipyridamole stress ECG 
Dobutamine stress echocardiography 
Cardiopulmonary exercise testing 
Class III (Goldman et al., 1977, 
Ridley, 2003) 
Class IV (Detsky et al., 1986, Ridley, 
2003) 
0 or 1 clinical risk factors (Lee et al., 
1999, Ridley, 2003) 
Negative test (Chassot et al., 2002) 
Negative test (Kertai et al., 2003) 
Negative test (Biccard, 2005) 
Cardiovascular complications fall broadly into two groups: that is sudden cardiac events 
(sudden cardiac death, myocardial infarction and arrhythmias) or cardiac failure. 
The commonly reported pre-operative special investigations either identify myocardial 
ischaemia as a marker of coronary artery disease and/or ventricular dysfunction as a 
marker of heart failure (Chassot et al., 2002). Myocardial ischaemia is identified either by 
ST segment depression using ambulatory or stress electrocardiography; or by detection of 
fixed or reversible myocardial perfusion defects using a vasodilator such as dipyridamole 
and an isotope such as thallium for imaging during myocardial perfusion scintigraphy; or 
by detection of new regional wall motion abnormalities of the left ventricle by 
echocardiography during dipyridamole stress echocardiography and dobutamine stress 
echocardiography (Chassot et al., 2002, Kertai et al., 2003). Poor ventricular function as a 
marker of heart failure determined by a low resting ejection fraction (usually accepted as 
less than 35%) measured with ventriculography (Kertai et al., 2003, Chassot et al., 2002). 
A meta-analysis of these pre-operative tests, showed that the tests with the lowest 
sensitivity were ambulatory and stress electrocardiography of ST depression and 
ventriculography measuring resting ejection fraction (Kertai et al., 2003). Tests which rely 
19 
solely on ECG changes (such as the ambulatory and stress ECG) are limited by existing 
ECG abnormalities. This has resulted in an unreliable analysis of the ST segment in up to 
40% of patients using the ambulatory ECG test (Rose et al., 1993). An additional problem 
with the exercise ECG test is the necessity for the patient to be able to exercise on a 
treadmill (Kertai et al, 2003). 
The problem with a static test of ventricular function, such as measuring the resting left 
ejection fraction, is that it does not reveal how the ventricle responds to exercise or 
increased cardiovascular demand associated with the stress response following surgery. 
The sensitivity of this test was the lowest of the six reported (Kertai et al., 2003). The 
reason for this is that firstly, there is a poor correlation between the resting and stress 
echocardiography in patients with cardiac failure (Lee et al., 2006), secondly there is a 
poor correlation between ejection fraction and maximal oxygen uptake in patients with 
coronary artery disease which is not limited by myocardial ischaemia (Older and Hall, 
2004) and thirdly dynamic tests of ventricular function may illicit myocardial ischaemia 
(which is not evident at rest) which would further compromise ventricular function. 
Pre-operative tests which identify myocardial ischaemia, whether by fixed or reversible 
deficits on imaging, or by regional ventricular wall motion abnormalities have a higher 
sensitivity, than ECG tests of ST depression or resting ventriculography (Kertai et al., 
2003). A further meta-analysis showed that dobutamine stress echocardiography had a 
statistically better negative predictive power than thallium scanning (Beattie et al., 2006). 
Stress echocardiography was significantly better at predicting cardiac events in positive 
patients, as stress echocardiography had less false negatives than thallium scanning 
(Beattie et al., 2006). 
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Cardiopulmonary exercise testing has never been compared in a meta-analysis to other pre-
operative investigations. There are a number of reasons to suggest that it would perform 
well if compared to other investigations. Firstly, it is specific as are the other desirable 
tests. (Tables 2.7 and 2.8) Secondly, although it measures ECG ST segment changes, it is 
not entirely depend on the ST segment for test interpretation. Thirdly, it is a test of 
dynamic ventricular function and not a static test. Fourthly, although it is exercise 
dependent, it is traditionally performed on a cycle ergometer, which is preferable to a 
treadmill as it eliminates weight bearing (Biccard, 2005). 
2.3. The requirements for an ideal pre-operative investigation of cardiac risk 
A pre-operative investigation conducted to estimate peri-operative cardiovascular risk 
associated with major surgery should be able to distinguish four groups of patients; 
patients who require no further intervention prior to surgery, patients requiring acute peri-
operative medical therapy (beta-blockade (Devereaux et al., 2005a, Biccard et al., 2006) 
and/ or statins (Biccard et al., 2005b, Biccard et al., 2005a)) peri-operatively, patients 
requiring peri-operative haemodynamic optimization (Kern and Shoemaker, 2002) and 
patients requiring coronary angiography and possible coronary revascularization (Eagle et 
al., 2002). 
The indications for coronary revascularisation in the surgical patient are the same as the 
non-surgical patient (Eagle et al., 2002). These include left main stem coronary artery 
stenosis, left main stem equivalent (significant stenosis of the proximal left anterior 
descending and left circumflex) or 3-vessel disease and disease associated with significant 
ischaemia on non-invasive testing or left ventricular dysfunction (Eagle et al., 2004). 
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The indications for pre-operative coronary angiography are listed in Table 2.9 (Eagle et al., 
2002). 
Table 2.9. The ACC/AHA Class I indications for coronary angiography in the pre-
operative evaluation for noncardiac surgery (Eagle et al.. 2002). 
Evidence for high risk of adverse outcome based on non-invasive test results 
Angina unresponsive to adequate medical therapy 
Unstable angina, particularly when facing intermediate or high-risk surgery 
Equivocal non-invasive test results in patients at high-clinical risk undergoing high-risk 
surgery _ _ 
ACC/AHA, American College of Cardiology/ American Heart Association 
Pre-operative revascularisation significantly decreases the risk of death and MI associated 
with intermediate and high-risk noncardiac surgery in patients where coronary 
revascularisation is indicated (Eagle et al., 1997). As pre-operative coronary 
revascularisation is associated with cardiovascular risk (Table 2.10), it is suggested that 
pre-operative revascularisation should only be considered where the expected mortality of 
the noncardiac procedure exceeds 5% and the combined mortality of the coronary 
angiography and revascularisation is less than 3% (Rihal, 1998). Patients with a peri-
operative cardiac mortality risk of less than 5% and an adverse peri-operative 
cardiovascular event rate risk of >10% probably would benefit from acute peri-operative 
beta-blockade (Biccard et al., 2006), and possibly peri-operative statin therapy(Biccard et 
al., 2005a). No studies have shown that prophylactic coronary revascularisation improves 
outcome when the complications of the revascularisation procedure are also considered 
(Bodenheimer, 1996, McFalls et al., 2004). 
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Consideration 
operative coronary revascularisation 
Risk 
Exercise stress testing 
Coronary angiography 




Delay of noncardiac surgery 
Pathology of subsequent 
peri-operative MI 
MI or death 0.04% (Stuart and Ellestad, 1980) 
Major complications <2% (Scanlon et al., 1999) 
Mortality 0.03-0.25% (Mason et al., 1995) 
Mortality 2.3% (Foster et al., 1986) 
Increased risk death, MI, CVA, renal failure in vascular 
patients (Lustik et al., 2002) 
Mortality 1-2% (Eagle et al, 2004) 
Morbidity associated with delay of noncardiac surgery 
45% are not associated with plaque disruption (Dawood et 
al., 1996), but rather prolonged periods of myocardial 
oxygen supply-demand imbalance (Landesberg et al., 
1993,Rappetal., 1999) 
26% do not occur in the territory identified by non-
invasive testing (Poldermans et al., 2001) 
Where the risk of peri-operative mortality is expected to exceed 20%, haemodynamic 
optimisation may be of benefit when it is instituted within 12 hours of surgery and before 
established organ failure (Kern and Shoemaker, 2002). 
Based on these management decisions the following peri-operative management algorithm 
can be instituted. (Table 2.11) 
Table 2.11. Proposed management algorithm of high-risk surgical patients 
Predicted peri-operative event rate Suggested management 
Major CVS complications >10% Acute peri-operative beta-blockade (Biccard et al., 
2006) 
Coronary angiography (Bodenheimer, 1996) and 
revascularisation 
Haemodynamic optimization (Kern and Shoemaker, 
2002) 
CVS mortality > 5% 
All cause mortality > 20% 
Based on the original work by Older and colleagues presented in Table 2.3 (Older et al., 
1993), it is possible to identify appropriate peri-operative management according to the 
23 
CPET result. (Table 2.12) This is the approach which has been followed in Durban since 
October 2004. 
Table 2.12. Peri-operative management of high-risk patients according to CPET 
result 
CPET result Peri-operative management 
Adequate AT, no early ischaemia 
Adequate AT without early ischaemia 
Poor AT without early ischaemia 
Poor AT with early ischaemia 
Consider acute peri-operative beta-blockade 
Acute peri-operative beta-blockade 
Haemodynamic optimisation 
Coronary revascularisation, with repeat CPET 
once recovered prior to noncardiac surgery 
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Chapter 3 
A literature review of cardiopulmonary exercise testing for noncardiac, 
non thoracic surgery 
3.1. Methods 
In order to review the literature on peri-operative cardiopulmonary exercise testing, a 
Medline search from 1966 to November 2005 was conducted. The terms used in the search 
were: cardiopulmonary, exercise, anaerobic, ventilatory, threshold and surgery. The search 
used the text words 'cardiopulmonary exercise' or 'anaerobic threshold' or 'anerobic 
threshold' or 'ventilatory threshold' and 'surgery'. 
All prospective trials were identified which reported the peri-operative outcome associated 
with documented pre-operative cardiopulmonary exercise test results. The reference lists of 
eligible trials (and systematic reviews) were also examined for further relevant trials. 
Trials were excluded where postoperative outcomes were not reported in the either the 
control or treatment groups. Where data publication was replicated, we used the 
publication which contained the largest number of subjects. 
Only data from human studies, published in the English language, are included in this 
review. The data abstracted from the trials included: the type of cardiopulmonary exercise 
test (treadmill, cycle ergometer or arm cranking), the endpoint measured in the test, the 
type of surgery scheduled for the patient, the peri-operative outcome in terms of all-cause 
and cardiovascular mortality. 
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3.2. Results 
Literature searching revealed 440 publications. Four-hundred and twenty-six publications 
were excluded for the following reasons; 198 trials reported on cardiac surgery and/ or 
interventional cardiology, 16 studies only used cardiopulmonary exercise testing 
postoperatively, 87 studies used cardiopulmonary exercise testing for other non surgical 
assessments, 71 studies were not English publications and 31 other exclusions including 
lung transplant and lung reduction surgery, pectus excavatum, reviews and where 
cardiopulmonary exercise testing was not done. Twenty-three papers describing the utility 
of CPET in thoracic resection were also not reviewed. 
The remaining 14 publications have been reviewed. These include four general surgical 
papers (Older et al., 1999, Older et al., 1993, Gerson et al, 1985, Gerson et al., 1990), one 
trial for aortic aneurysmal surgery (Nugent et al., 1998), one trial for oesophagectomy 
(Nagamatsu et al., 2001), two for hepatic transplant (Epstein et al., 2004, Wiesinger et al., 
2001), two for obesity surgery (Kanoupakis et al., 2001, Dolfing et al., 2005), three trials 
for major joint arthroplasty (Philbin et al., 1995, Ries et al., 1995, Ries et al., 1996) and 
one trial for obstructive sleep apnoea surgery (Lin et al., 2005). 
3.3. Discussion 
3.3.1. The type of CPET performed and the format of data reporting 
The CPET performed either included a maximal symptom limited exercise test (V02peak) 
(Philbin et al., 1995, Nugent et al., 1998, Ries et al., 1995, Ries et al., 1996, Nagamatsu et 
al., 2001, Epstein et al, 2004, Lin et al., 2005, Dolfing et al., 2005, Kanoupakis et al, 
2001), or an AT test (Older et al., 1993, Older et al , 1999, Wiesinger et al., 2001), or the 
ability to cycle for two minutes to a heart rate exceeding 99 beats per minute (in patients 
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who were not beta-blocked) (Gerson et al., 1985, Gerson et al., 1990). A cycle ergometer 
was used exclusively in eleven studies, one study used arm cranking (Philbin et al., 1995) 
in addition to cycling and two studies used a treadmill (Nugent et al., 1998, Kanoupakis et 
al., 2001). The reporting of exercise capacity varied between studies and included VO2 as a 
percentage of predicted (Epstein et al., 2004, Dolfing et al., 2005, Wiesinger et al., 2001, 
Ries et al., 1995, Ries et al., 1996), V0 2 in ml.min"' (Dolfing et al, 2005, Wiesinger et al., 
2001, Philbin et al., 1995, Lin et al , 2005), ml.kg"1.min"1 (Philbin et al., 1995, Older et al, 
1999, Older et al., 1993, Nugent et al., 1998, Kanoupakis et al., 2001, Ries et al., 1995, 
Ries et al., 1996, Lin et al., 2005) or ml.min'.m"2 (Nagamatsu et al., 2001). 
The great variation in the test used (arm cranking, cycling or treadmill) will all affect the 
time of onset of the AT, due to different muscle volumes and recruitment (Biccard, 2005) 
with a lower AT associated with smaller muscle groups, such as arm cranking in 
comparison to cycling. The reporting of either AT, V02peak or both means that comparison 
between studies is not always possible. The inconsistent units used for reporting of VO2 
makes it difficult to compare outcomes between studies, in particular where the VO2 data 
are only reported as ml.min"1 (Lin et al., 2005). 
3.3.2. The ability of an individual to complete a cardiopulmonary exercise test 
If cardiopulmonary exercise testing is to become more commonly applied, the majority of 
patients should be able to perform the test (it should have a low drop out rate). The 
noncardiac, non-thoracic surgical literature has a drop out rate of 2.2% (32 patients out of 
1459 included in studies for testing) (Older et al., 1999, Dolfing et al., 2005, Kanoupakis et 
al., 2001, Older et al., 1993, Ries et al., 1996, Ries et al , 1995, Philbin et al., 1995, 
Wiesinger et al., 2001, Epstein et al., 2004, Nugent et al, 1998, Lin et al, 2005, Gerson et 
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al., 1990, Gerson et al., 1985). However, seven of these 32 patients did not fail to complete 
the test, but rather were excluded for other reasons (Wiesinger et al., 2001). The actual 
drop out rate is then 1.7%. One study did not record the drop out rate (Nagamatsu et al., 
2001). Looking at specific groups: all 72 morbidly obese patients (defined as a body mass 
index (BMI) > 40 kg.m"2) had reached the AT, on both treadmill and cycle ergometer tests 
(Dolfing et al., 2005, Kanoupakis et al., 2001). In patients undergoing knee arthroplasty, 
severe osteoarthritis did not prevent these patients from achieving the AT during testing 
(Ries et al., 1996, Ries et al., 1995). In patients with either severe rheumatoid arthritis and 
osteoarthritis for hip and knee replacements, only a single patient (2%) with rheumatoid 
arthritis could not sustain 60 repetitions per minute (RPM) with either arm cranking or 
cycling (Philbin et al., 1995). It appears therefore that osteoarthritis is not a limiting factor 
in cardiopulmonary exercise testing. 
All the patients scheduled for hepatic transplantation who have been reported in the 
literature have also successfully completed exercise testing to AT (Wiesinger et al., 2001) 
and to VO2 peak (Epstein et al., 2004). However, exclusion criteria had included hepatic 
encephalopathy, intrinsic cardiac and/ or pulmonary disease (Wiesinger et al., 2001). These 
exclusion criteria account for the seven of the 32 drop outs recorded (Wiesinger et al., 
2001). 
The inability to exercise is not necessarily a limitation associated with CPET as a pre-
operative investigation. Indeed, it is an important prognostic marker. In 100 patients 
undergoing abdominal or noncardiac thoracic surgery, all 5 cardiac deaths were found in 
the group unable to cycle for 2 minutes to a heart rate of >99 beats per minute (Gerson et 
al., 1985). This approach which is partly based on a heart rate target is now inappropriate 
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with the increased utilisation of beta-blockade for managing patients with a history of 
ischaemic heart disease (Freemantle et al., 1999) and congestive cardiac failure (Metra et 
al, 2004). 
3.3.3. Cardiopulmonary exercise testing for major abdominal surgery 
The original work on this group of patients described by Older and colleagues (Older et al., 
1993, Older et al., 1999) has already been discussed in Chapter 2 in the section titled; 
'Determinants of peri-operative cardiac risk 2.1.3. Functional capacity and aerobic 
metabolic capacity.' Importantly, even when Older and colleagues triaged and managed 
the patients with poor cardiopulmonary test results more aggressively, the cardiac mortality 
was still significantly higher in the patients with a low AT (Older et al., 1999). It appears 
therefore that a poor aerobic capacity remains a significant cardiovascular risk factor 
despite intervention. However, an aggressive management approach does decrease 
mortality in this group (Older et al., 1999, Older et al., 1993). 
3.3.4. Cardiopulmonary exercise testing for major vascular surgery 
There is a single report in the peer-reviewed literature of cardiopulmonary exercise testing 
for the pre-operative assessment of abdominal aortic aneurysms (Nugent et al., 1998). 
Unfortunately, this is a small series of 30 patients having abdominal aortic 
aneurysmectomy. Patient cardiovascular risk was quantified by the presence of a VO2 peak 
less than 83% of predicted, an AT less than the predicted 95% confidence interval, an 
oxygen pulse less than the predicted 95% confidence interval and ischaemic ST depression 
of greater than -1 mm. Not surprisingly this paper could not show utility associated with 
cardiopulmonary exercise testing as the patients were of extremely low cardiovascular risk 
and the corresponding event rate was thus low. Twenty-six of the 30 patients had less than 
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two of these risk factors and there was a single peri-operative cardiac death (Nugent et al., 
1998). There was a trend however to increased peri-operative complications associated 
with a poorer CPET result. Their conclusion was that cardiopulmonary exercise testing 
may be helpful in identifying patients at risk of more postoperative complications, 
although it should not be used in isolation without thorough clinical assessement (Nugent 
et al., 1998). Hence, this again suggests that the philosophy of combining clinical risk 
factors, results of specific investigations and surgical risk may improve peri-operative 
prognostication. 
An abstract reports on CPET for aortic aneurysm surgery in York, United Kingdom 
(McEnroe and Wilson, 2005). The mortality in the group with an AT < 11 ml.kg"1.min"1 
was 11% and 6% for the patients with an AT above 11 ml.kg"'.min"1. However, the authors 
did not distinguish between cardiac deaths and other deaths. Patients who had a low AT 
and a history of ischaemic heart disease had an all-cause mortality of 19%. It was 
concluded that CPET is useful in stratifying patients for vascular surgery (McEnroe and 
Wilson, 2005). 
3.3.5. The prognostic importance of the time of onset of myocardial ischaemia 
during cardiopulmonary exercise testing 
It has been shown that early myocardial ischaemia (that is within two minutes of the onset 
of unloaded exercise) during cardiopulmonary exercise testing is a predictor of a worse 
outcome (Older et al., 1999). This may be because myocardial ischaemia is present at an 
oxygen consumption equivalent to that expected in the postoperative period (about 1.4 
METs) (Biccard, 2005). During unloaded cycling, the predicted METs expended is 
equivalent to 2.5 to 2.6 METS for men and women respectively, using the following 
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nomogram (V02 unloaded cycling (ml.min"
1) = 150 + (6 x weight (kg)), at a cadence of 50 
to 60 RPM (York, 2005). It is possible therefore that ischaemia during the early period of 
unloaded cycling may indeed be at an oxygen consumption equivalent to that of the 
cardiovascular stress associated with the surgical stress response. 
3.3.6. The potential utility of the oxygen pulse for peri-operative prognostication 
The oxygen pulse is determined by stroke volume and peripheral uptake of oxygen 
(Wasserman et al., 2005). It is known that peripheral oxygen extraction falls 
postoperatively (Older and Smith, 1988, Older et al., 1993, Davies and Wilson, 2004). It is 
possible that patients who increase their oxygen pulse (and hence possibly their oxygen 
extraction) during CPET, over a metabolic range commensurate with postoperative 
requirements may be at increased postoperative risk. It would be reasonable to examine the 
oxygen pulse response between a VO2 of 5 ml.kg'.min" (the expected oxygen 
consumption following major surgery (Older and Smith, 1988, Davies and Wilson, 2004)) 
and 7 ml.kg^.min"1 (the maximum expected oxygen consumption postoperatively (Davies 
and Wilson, 2004)). This has not been previously investigated. 
3.4. Recommendations 
The methodology and reporting used in the studies reviewed were not standardised. It is 
therefore difficult to compare outcomes in a meta-analytical fashion. The need for a 
standardised pre-operative CPET is needed, where surgical and patient clinical risk factors 
are reported, as well as the AT, the VO2 peak, and the units used to present the data. The 
time and definition of onset of significant myocardial ischaemia and the heart rate and 
oxygen pulse response to exercise also need to be standardised. 
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Chapter 4 
Cardiopulmonary exercise testing in Durban 
Methods 
CPET was started as a clinical service at IALCH in October 2004, to investigate high-risk 
surgical patients prior to surgery. Prognostication was based on the original data published 
by Older and colleagues (Older et al., 1993). All patients undergoing major vascular 
surgery were referred pre-operatively for CPET. In addition, all patients with clinical risk 
factors suggestive of high cardiac risk irrespective of the surgery were also referred for 
CPET. Between October 2004 and June 2006, 95 patients were referred for CPET at 
IALCH. 
Ethics approval was granted by the Ethics Committee of the Nelson R Mandela School of 
Medicine to abstract data retrospectively for patients who had undergone CPET. The letter 
of ethical approval and data abstraction sheet is shown in the appendix. 
4.1. The cardiopulmonary exercise test 
4.1.1. Equipment and calibration 
Test equipment included a Monark® 970 cycle ergometer (Monark Exercise AB, Vansbro, 
Sweden), an online 12 lead ECG and a metabolic cart. For arm cranking the cycle 
ergometer is mounted on a table, as we do not have an arm crank. The 12 lead ECG was 
able to show ST segment changes in all leads. The Schiller CS-200® metabolic cart 
(Schiller AG, Baar, Switzerland) has an oxygen fuel cell (paramagnetic) (Schiller, 2003) 
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and a carbon dioxide (ultrasound density) (Schiller, 2003) analyser capable of breath-by-
breath gas analysis measurement. 
Calibrations of flow and volume measurements and gas analysers were made prior to 
testing according to the manufacturer's instructions on each day of CPET. The flow 
measurement device was calibrated using a syringe of known volume (2L) (Schiller, 2003) 
over various flow rates. The gas analyser's calibration uses a two point calibration 
corresponding to the equivalent of normal gas concentrations at sea level and exhaled gas 
concentrations (from the calibration gas cylinder containing a gas mix of 5.2% carbon 
dioxide in nitrogen). In addition, the gas calibration includes a measure of the delay 
between the change in gas concentration at the distal end of the sample line and the time it 
takes for this change to be measured by the gas analysers, in order to align gas analyser 
data with flow meter measurements (York, 2005). 
4.1.2. Preparation of the cardiopulmonary exercise test 
We have followed the Consensus Protocol for Pre-operative CPX Testing for York, Torbay 
and UCLH (York, 2005). In addition, we added arm cranking to our testing procedure. All 
patients for major vascular surgery were routinely referred for pre-operative CPET. In 
addition, any patients deemed to be of a high-cardiovascular risk and with a confusing 
clinical picture presenting for elective surgery, were also referred. 
Basic demographic and clinical risk factors associated with cardiac risk were recorded. 
Patients with absolute contra-indications for CPET were excluded. (Table 4.1) In patients 
referred with aortic aneurysms, the CT angiograms were reviewed to ensure that there was 
no evidence of leaking of the aortic aneurysm. 
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Table 4.1. Absolute contra-indication for CPET (York, 2005, ATS/ACCP, 2003) 
Contra-indication Definition 
Acute myocardial infarction 
Uncontrolled arrhythmias 









Dissecting or ruptured 
aneurysm 




Thrombosis of limbs 
Within 7-10 days of transmural infarct or within 5 days 
if minor and uncomplicated 
Symptomatic or haemodynamically compromise 
> 50% stenosis 
< 85% while breathing room air 
Pain free for < 4 days 
Limbs required to perform exercise test 
The test was conducted by myself or Dr N. Kalafatis, with the assistance of a respiratory 
technologist. Full resuscitation equipment and emergency drugs were readily available. All 
patients gave informed consent for CPET. 
Patients were allocated on their ability to perform cycle ergometry. Only patients with 
peripheral vascular disease and claudication, who were unable to cycle were allocated to 
arm cranking. Patients were either positioned on the bike or at a table with the cycle 
ergometer on the table for arm cranking. The knee had 5 degrees of flexion, with the foot 
in the neutral position on the pedal at the bottom of the cycle stroke. A Hans Rudolph® 
8900 Series nasal and mouthbreathing mask was connected to the respiratory gas analysis 
lines and held in position with a Hans Rudolph head cap. The patients were requested to 
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give their 'best effort', although they could stop if they felt uncomfortable or faint. The 
patients were instructed in the importance of maintaining 60 RPM during the test, as the 
power calibration is dependent on both the revolutions and the resistance applied to the 
flywheel. 
The objective was to conduct a ramp test of 10 minutes duration. As our ergometer is not 
mechanically ramped, the increment in work was adjusted every minute, which is 
acceptable for measuring the anaerobic threshold (Wasserman et al., 2005). The rate of 
increment in work was predetermined by the formulae shown in Table 4.2. (York, 2005). 
Although, the calculation used for unloaded VO2 is specifically for cycling, we used it in 
our calculations for arm cranking as well. As 10 ml.min"1 VO2 is approximately equivalent 
to an increase in 1 watt of power (Wasserman et al., 2005), the expected difference in VO2 
between unloaded and peak VO2 can be converted into watts per minute over a 10 minute 
period. 
Table 4.2 Calculations for predicted oxygen consumption (York, 2005) 
Definition Calculation 
IJnlo^d^dVC^ VOlunloaded ( m i m i n g 150 + (6 x"weighF(kg)) 
Peak VO2 female Peak VO2 (ml.min1) Women = height (cm) - age (years) x 14 
Peak VO2 male Peak VO2 (ml.min"1) Men = height (cm) - age (years) x 20 
Increment in work rate (Watts.min"1) = (Peak VO2 - Unloaded V02) /100 
per minute 
4.1.3. The stages of the cardiopulmonary exercise test 
The test consists of four stages: rest, unloaded cycling, ramp and recovery. The patient sits 
for approximately three minutes during the rest phase when rest data are collected. This 
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includes resting ECG, blood pressure, peripheral oxygen saturation, baseline ST analysis 
and respiratory gas analysis. This also allows the respiratory exchange ratio to fall, as some 
patients are anxious on presentation for the test. This is followed by three minutes of 
unloaded cycling. This stage, by providing minimal resistance to exercise, allows for 
oxygen-dependent enzyme induction (VCh-on-kinetics) prior to ramping (Biccard, 2005). 
Ramping then starts, with a ramp in wattage according to the predetermined calculations, 
effected every minute until the anaerobic threshold was believed to be exceeded. 
Monitoring during the test included the 12 lead ECG with ST analysis and breath to breath 
analysis of VO2, carbon dioxide production (VCO2), minute ventilation and the respiratory 
exchange ratio (RER). 
The blood pressure and peripheral oxygen saturation was measured on termination of the 
test. The ECG was measured until any dysrhythmia or ST changes have reverted to pre 
test levels or alternatively until heart rate was within 10 beats per minute of the pre test rate 
(York, 2005). 
4.1.4. Termination of the cardiopulmonary exercise test 
The test was terminated if the anaerobic threshold was attained (Table 4.3), if myocardial 
complications compromised patient safety (Table 4.4) or the patient terminated the test. 
The test was deemed terminated by the patient if he or she stopped pedalling before the 
other criteria were obtained (Tables 4.3 and 4.4) or the patient failed to maintain more than 
30 revolutions per minute for more than 1 minute, despite encouragement (York, 2005). 
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Table 4.3. Determination of the Anaerobic Threshold (York, 2005, Wasserman et al., 
2005) 
Using a combination of the following: 
Rising ventilatory efficiency for oxygen, despite a plateau for carbon dioxide 
RER>1 
Rising End Tidal Oxygen, which precedes a fall in end tidal carbon dioxide 
Cross over of VCO2 and VO2 when plotted on same axis 
Increase in gradient of VCO2 vs VO2, which exceeds 1 
Table 4.4. Myocardial complications demanding termination of the CEPT (Older et 
al, 1999, York, 2005) 
New S-T segment changes exceeding -2.0 mm (depression) or +3.0 mm (elevation) 
New dysrythmia occurs 
The AT is usually measured using the modified V-Slope method and is confirmed by 
changes in other variables such as the respiratory exchange ratio, ventilatory efficiency and 
end tidal values for oxygen. The V-slope method is based on the assumption that the slope 
of a VCO2-VO2 graph cannot exceed one. However, with increased glycolytic metabolism 
and lactate production, the associated bicarbonate buffering of protons results in an 
increase in VCO2 and the slope of the VCO2-VO2 graph exceeds one. The point at which 
this occurs is the AT determined by the V-slope method (Wasserman et al., 2005). 
Other methods of confirming the anaerobic threshold are the ventilatory equivalent 
method. Here with buffering of protons, there is a period of isocapnic buffering following 
the anaerobic threshold, where the ratio of minute ventilation (VE) to VO2 increases 
without an increase in VO2/VCO2 (Wasserman et al., 2005). Because of the relative 
hyperventilation with respect to oxygen consumption at the anaerobic threshold, the end 
tidal oxygen concentration (PET02) increases while the end tidal carbon dioxide 
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concentration (PETC02) only starts to decrease approximately 2 minutes later (Wasserman 
et al., 2005). 
4.2. Interpretation of the cardiopulmonary exercise test results 
4.2.1. Anaerobic threshold 
A low anaerobic threshold was defined as a positive test result. For cycling, an AT < 11 
ml.kg"1.min"1 was considered a positive test result (Older et al., 1993, Older et al., 1999). 
As far as arm cranking was concerned, the definition of a low AT which is prognostic for 
major surgery is not defined. As the muscle mass of arms is smaller than that of the legs, 
more work is done by the smaller muscle mass in order to maintain the workload and 
hence the AT is reached at a lower level. The AT relative to the VO2 peak has been shown to 
be 46.5 (± 8.9)% for arm cranking and 63.8 (± 9.0)% for cycling (Davis et al., 1976). 
Therefore the AT of arm cranking was approximately 73% of that recorded during cycling. 
However, this is complicated by the fact that the more severe the pathology of the legs, the 
more an individual will depend on the arms during activities, resulting in a relative 
increase in the aerobic capacity of the arms. Hence one would expect these patients to 
have a relative increase in AT for arm cranking in comparison to cycling. This is borne out 
in research of orthopaedic patients scheduled for major joint replacement of knees and 
hips, with a mean AT of 10.6 (+ 2.4) ml.kg"1 .min"1 in the cycle group and an AT in the arm 
cranking of 8 (± 1.7) ml.kg"1.min"1 (Philbin et al., 1995). The AT of arm cranking is thus 
75% of the AT of cycling in this study. The arm cranking and leg cycling groups were not 
statistically compared, although cycling mean age and weight were 67.7 (+ 1 SD 9.3) years 
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and 82.8 ((+ 1 SD 20.1) kg and arm cranking mean age and weight were 67.4 ((+ 1 SD 7.4) 
years and 86.4 ((+ 1 SD 15.8) kg respectively (Philbin et al., 1995). 
Paraplegic patients have an AT 18% higher than able-bodied people when arm cranking, 
probably secondary to metabolic and muscle adaptations associated with an increased 
reliance on arm exercise (Schneider et al., 1999). 
There appears to be no work on the effect of peripheral vascular disease on subsequent arm 
power (JV Robbs, personal communication). However, with less pedal mobility, a similar 
increase in aerobic arm functional performance is assumed, in keeping with changes seen 
with paraplegic patients (Schneider et al., 1999). However, the increase in aerobic capacity 
of the arms could not be considered to be equivalent to that of paraplegics, as patients with 
peripheral vascular disease still have pedal mobility. Hence it was assumed that the 
increase in arm aerobic capacity to be approximately 50% of that seen in paraplegics, 
hence approximately 9% higher than that routinely observed (Philbin et al., 1995, Davis et 
al., 1976). Therefore the equivalent to 11 ml.kg"1.min"1 for cycling, was 9 ml.kg"1.min" for 
arm cranking, based on an expected AT of with arm cranking of 73% of that recorded with 
cycling (Philbin et al., 1995), plus 9% for improved aerobic arm function, resulting in a 
predicted AT for arm cranking of 82% of that recorded for cycling. 
4.2.2. The time of onset of significant myocardial ischaemia 
Early myocardial ischaemia was defined as myocardial ischaemia occurring within two 
minutes of unloaded exercise (Older et al., 1999), and was considered a positive result for 
myocardial ischaemia. 
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4.3. Classification of cardiac outcome 
All in-hospital deaths in patients who had undergone CPET were analysed by two 
independent assessors. One was a surgeon (Professor D. Muckhart) and the other an 
anaesthetist (Dr S. Bechan), both working in postoperative intensive care. Both were 
blinded to the patients' CPET results. They were asked to determine if a death was 
primarily cardiac in origin or not. To fulfil these criteria, the cardiac event had to be 
deemed the primary precipitant leading to death. Cardiac deaths were classified as 'sudden 
cardiac death' (AMI or cardiac arrest) and cardiac failure (increasing inotropic 
requirements without an obvious precipitant cause). The assessors had access to all clinical 
notes and investigations conducted on the patients. They independently determined the 
cause of death. The assessors then conferred and if there were any discrepancies regarding 
the cause of death these were resolved through discussion and consensus was reached. 
4.4. Statistical methods 
SPSS 13.0 for Windows (1 Sept 2004) was used for data analysis. The distribution of 
demographic variables was analysed. Levene's test for equality of variances was 
conducted, when comparing independent data using a two tailed Student's T-test. The two 
tailed Fisher's Exact Test was performed when analysing categorical data. Alpha was set at 





5.1. The outcome of all patients referred for CPET 
Ninety-five patients were referred for CPET. The subsequent management following 
referral for CPET, as of the middle of November 2006, is reported in Table 5.1. 
Table 5.1. Management of patients referred for CPET 
Outcome Number of patients (percentage) 
CPET done and vascular surgery completed 
CPET done and awaiting surgery 
Excluded from analysis 
58 (61 %) 
18(19%) 
19(20%) 
The reasons for excluding nineteen patients from analysis is listed in Table 5.2. 
Table 5.2. Exclusion criteria of patients referred for CPET 
Exclusion criteria Number of patients (percentage) 
CPET contra-indicated 
CPET done and patient absconded 
CPET done and surgical pathology managed 
conservatively 
CPET done and died prior to surgery 





3 (16 %) 
Of the three patients in whom CPET was contra-indicated; one had a dissection of the 
common iliac artery and two had evidence of rupture of abdominal aortic aneurysms. 
5.2. Patient demographics 
The demographics of the patients are shown in Table 5.3. Height and weight were 
normally distributed, while age was skewed to the right, with a skewness of-1.416. The 
median age (range) was 68 years (15 to 90) with an interquartile range of 58; 72 years. 
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There was no difference in the demographics between the patients included in this analysis 
and the excluded patients from Table 5.2. Levene's Test for Equality of Variances was not 
significant for age, height or weight and hence equal variances are assumed. 







46 (79%)/12 (21 %) 
63 ± 13.4 t 
69.1 ± 13.0 t 
168.20 ± 7.4 | 
Excluded patients 
15 (79%)/4 (21%) 
67 ± 12.5 f 
65.5 ± 18.3 t 






5.3. Cardiopulmonary exercise test results 
Twenty-seven patients performed arm cranking and 31 patients underwent cycle 
ergometry. Levene's test for equality of variances was not significant (p=0.679). The two 
tailed t-test for independent variables found the AT to not be significantly different 
between the arm cranking and cycling groups (p=0.069). The AT results are shown in 
Table 5.4. 
Table 5.4. Group anaerobic threshold results expressed in ml.kg"1.min"1 
Test Mean+ISD 95% CI T value P value 
Arm cranking 11.7±3.8 10.1-13.3 -1.862 0.069 
Cycle ergometer 13.7 ±3.6 12.7-14.6 
5.4. Cardiac outcome according to surgical procedure 
The cardiac deaths classified according to surgical procedures are shown in Table 5.5. 
Cardiac deaths only followed aortic surgery. This included both open and endovascular 
procedures. 
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Table 5.5. Outcomes related to specific vascular surgical procedures 
Vascular surgical procedure N subjects N (percentage) 
cardiac deaths 
Emergency abdominal/ thoracic 











2 (20 %) 
0 (0 %) 
0 (0 %) 
N = number of; EVAR = endovascular aortic aneurysm repair 
5.5. Subgroup analysis of patients undergoing surgery associated with reported 
cardiac mortality 
An analysis of the subgroup of the 50 patients undergoing the elective vascular surgical 
procedures with reported cardiac mortality (abdominal / thoracic and EVAR) was 
conducted. This group had a cardiac mortality of 16%. As this is an analysis of outcome 
following major elective vascular surgery, the single emergency procedure is excluded. 
5.5.1. Anaerobic threshold 
Using a positive test result of an AT < 11 ml.kg^.min"1 for the cycle ergometer and an AT 
< 9ml.kg"1.min"1 for the arm cranking, this test was found to not be significantly associated 
with cardiac death. (Table 5.6) 
Table 5.6. Anaerobic threshold and cardiac outcome 
Anaerobic threshold Cardiac deaths Survivors 
Low 3 (33 %) 6 




Fisher's Exact Test 2-tailed p=0.144. 
As this study design is a retrospective cohort, the relative risk is used (as opposed to the 
odds ratio). The risk ratio associated with cardiac death following a low AT was 2.73 [95% 
CI 0.79-9.41]. The sensitivity was 0.38 [95% CI 0.10-0.74], the specificity was 0.86 [95% 
CI 0.71-0.94], the positive predictive value was 0.33 [95% CI 0.09-0.69] and the negative 
43 
predictive value was 0.88 [95% CI 0.73-0.95]. The positive likelihood ratio is 2.7 and the 
negative likelihood ratio is 0.7. 
The area under the curve for receiver operating curves for arm cranking and cycle 
ergometry were both insignificant (p=0.50 and p=0.61 respectively) and thus the sample 
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1 - Specificity 
Figure 5.1. ROC for AT measured during arm cranking and cardiac mortality 
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ROC Curve 
1 - Specificity 
Figure 5.2. ROC for AT measured during cycling and cardiac mortality 
5.5.2. The change in oxygen pulse and heart rate between a VO2 of 5 and 
7 ml.kg' .min 
Analysis of the heart rate difference between 5 and 7 ml.kg'.min"1 (the expected and 
maximum expected oxygen consumption following surgery respectively) and the 
percentage change in oxygen pulse between 5 and 7 ml.kg" .min"1 revealed no statistical 






Oxygen pulse (%) 
Heart rate (bpm) 
16.7 ±10.1 
18.5 ±18.0 
13 ± 8 
12 + 9 
Table 5.7 The change in oxygen pulse and heart rate between 5 and 7 ml.kg^.min" 
during CPET for low and high anaerobic threshold groups 




The nine low anaerobic thresholds reported are shown in Table 5.8. None of these patients 
had early myocardial ischaemia. Using the decision analysis flow diagram of Wasserman 
et al all the patients were shown to be limited primarily by cardiac function (as opposed to 
respiratory or pulmonary vascular disease). 
Table 5.8. Details of the nine patients with a low AT. 
Patient AT Arm/ Outcome Oxygen pulse at specified 
V02 (ml.kg-'.min
1) 
Cycle 5 7 % change in 
oxygen pulse 
HR at specified V02 
(ml.kgVmin"1) 
5 7 Increase 
inHR 
48 9.38 Cycle Survived 4.4 4.8 9 110 126 16 
54* 9.18 Cycle Survived 6.6 7.8 18 47 60 13 
74 6.60 Arm Survived 3.3 3.6 9 98 123 25 
80 9.90 Cycle Survived 4.6 5.2 13 103 108 5 
86* 10.10 Cycle Survived Indeterminate as VO2 at rest > 7ml.kg",.min"1 
88* 9.30 Cycle Survived 6.1 6.6 8 64 81 17 
14 8.63 Arm Diedf 4.2 4.7 12 84 105 21 
24* 5.00 Cycle Died| 4.8 6.5 35 73 76 3 
22* 10.80 Cycle DiedJ 4.6 5.9 28 77 84 7 
* Patients on chronic beta-blockade; |cardiac failure; $ sudden cardiac death following 
postoperative myocardial ischaemia 
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The mean difference (+ 1 SD) in the increase in the oxygen pulse between a VO2 of 5 and 7 
ml.kg"1.min"1 for the survivors and non-survivors respectively was 11.5 + 4.2 and 25.2 + 
12.1 percent. This approached significance with a t-value of 2.417 and a p value of 0.052. 
The mean difference (+ ISD) in heart rate (HR) between a VO2 of 5 and 7 ml.kg"1.min" for 
the survivors and non-survivors respectively was 15.2 + 7.2 and 10.3 + 9.5 beats per minute. 
This was not significant with a t-value of 0.829 and a p value of 0.439. 
Analysis of the patients with a high AT, showed that the mean difference (+ ISD) in the 
increase in the oxygen pulse between a VO2 of 5 and 7 ml.kg"1.min"1 for the survivors and 
non-survivors respectively was 18.5 + 18.8 and 18.7 + 13.2 percent. This was not 
significant with a t-value of-0.16 and a p value of 0.987. 
5.5.3. Early myocardial ischaemia during CPET 
Three of the patients out of the 95 patients referred for CPET had early myocardial 
ischaemia during CPET. The first and third patients had an acceptable AT and the second 
patient had a low AT. Based on the reported cardiovascular mortality by Older and 
colleagues in elderly patients undergoing major abdominal surgery, the expected mortality 
was 4% for the first patient and 42% for the second patient (Older et al., 1993). As a result, 
the first patient was acutely beta-blocked for the peri-operative period and underwent 
endovascular aneurysm repair (EVAR). This patient had an early postoperative cardiac 
death. The second patient was referred for coronary angiography, which found three vessel 
coronary artery disease with tight ostial stenosis of the left mainstem requiring coronary 
artery bypass grafting. Based on the outcomes of the first two patients, the third patient 
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was referred to the cardiologists. The outcome of the cardiological assessment is still 
awaited. 
5.5.4. Clinical risk factors 
Lee's Revised Cardiac Risk Index (Lee et al., 1999) was found to be non predictive of 
cardiac death (Table 5.9). 
Table 5.9. Lee's RCRI and cardiac outcome 
Lee's RCRI 
0 or 1 risk factors 










Fisher's Exact Test 2-tailed p=0.67 
5.5.5. Left ventricular ejection fraction 
A traditional cut-off of an ejection fraction of < 35% was used as a predictor of a high-risk 
patient previously in Durban. This was also non predictive of cardiac mortality. (Table 
5.10) 
Table 5.10. Ejection fraction and cardiac outcome 
Ejection fraction Cardiac deaths Survivors Total 
<35% 0(0%) 1 1 
>35% 7(17%) 34 41 
Fisher's Exact Test 2-tailed p=1.00 
5.5.6. Chronic medical therapy 
The cardiac outcome associated with chronic statin and beta-blocker therapy is shown in 
Tables 5.11 and 5.12. 
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Table 5.11. Pre-operative statin therapy and cardiac outcome 
Statin therapy Cardiac deaths Survivors Total 
No therapy 6(15%) 33 39 
On therapy 2(18%) 9 11 
Fisher's Exact Test 2-tailed p=1.00 
Table 5.12. Pre-operative chronic beta-blocker therapy and cardiac outcome 
Chronic beta-blocker Cardiac deaths Survivors Total 
therapy 
No therapy 4(11%) 31 35 
On therapy 4 (37%) 11 15 




Due to the small sample size (despite nearly two years of a CPET clinical service), a 
number of important clinical issues cannot be statistically verified. In addition, the findings 
which are statistically significant have such small numbers in the contingency tables that a 
type one error cannot be excluded. However, the importance of the data presented here, 
cannot be ignored. 
6.1. Surgical risk 
Cardiac deaths were only recorded in patients undergoing surgery involving the abdominal 
and/ or thoracic aorta (both open and closed procedures). The most striking characteristic 
of the data presented is that the cardiac mortality is high; 18% for the group as a whole and 
60% in patients with a low anaerobic threshold and 12% with an acceptable anaerobic 
threshold. This is higher than the cardiac mortality expected from the international 
literature of aortic surgery (NCEPOD, 2005, Le Manach et al., 2005). The all-cause 30-day 
mortality for elective abdominal aneurysm repairs was 6.2% in the NCEPOD report on 
2004 practice in the United Kingdom (NCEPOD, 2005). In addition, the mortality in both 
high and low AT groups was higher than similar groups for aortic surgery in the United 
Kingdom (McEnroe and Wilson, 2005). The reasons for our high cardiac mortality could 
include higher cardiovascular risk associated with epidemiological transition (Opie and 
Mayosi, 2005), associated with suboptimal primary medical care in our population 
(MRC/BHF, 2002, Biccard et al., 2005b). 
*-T 070232 
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The numbers presently are too small in this study to stratify patients statistically according 
to procedures of different surgical risk. However, clinically all the cardiac deaths are in the 
aortic surgery group. This is consistent with the published literature (Kertai et al., 2005), 
where aortic surgery is the most important elective surgery cardiovascular risk subgroup. 
Compared to carotid endarterectomy (as a reference procedure) which is considered the 
lowest cardiovascular risk group associated with vascular surgery, the odds ratio associated 
with thoraco-abdominal or abdominal aortic surgery was 13.1 (95% CI 3.6-47.7) (Kertai et 
al., 2005). This clearly has an important clinical application, as the alternative surgical 
option of an 'extra-anatomic' shunt had no mortality in this cohort, even when the 
anaerobic threshold was poor. This is consistent with other reports of surgical risk. 
Surgical risk is more reliable at identifying the true negatives (Ridley, 2003), that is 
patients undergoing low or intermediate risk surgery are unlikely to have an adverse 
cardiac outcome (Ali et al., 2000). Surgical risk is specific (Ali et al., 2000) (and thus an 
adverse outcome would be unlikely in low risk surgery). 
6.2. The cardiopulmonary exercise test result 
A low AT was not statistically associated with peri-operative cardiac death in this study, as 
some of these patients still survived despite a low anaerobic threshold. (Table 5.6) The 
question is whether these patients could be predicted. 
6.2.1. The low anaerobic threshold without early myocardial ischaemia 
It may be possible to predict survivors with a low AT, if one examines the cardiovascular 
response during CPET to increasing VO2 from 5 ml.kg" .min" (the expected oxygen 
consumption following major surgery (Older and Smith, 1988, Davies and Wilson, 2004)) 
to 7 ml.kg"1 .min"1 (the maximum expected oxygen consumption postoperatively (Davies 
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and Wilson, 2004)). (Table 5.7) The survivors increase their heart rate more than non-
survivors, while the non-survivors increase their oxygen pulse more than survivors. The 
latter response is approaching statistical significance. (Table 5.8) Conversely, beta-blocked 
patients who died, could not increase their heart rate by 10 bpm and simultaneously 
increased their oxygen pulse by > lml.kg"1.min"1. 
This response is in physiological agreement with what we understand about the 
postoperative period. Patients who rely more on increasing their oxygen pulse (non-
survivors) than their heart rate (survivors) are at risk postoperatively. The oxygen pulse is a 
function of the increasing stroke volume and peripheral uptake of oxygen (Wasserman et 
al., 2005). The dependence on increasing oxygen extraction peripherally, is compromised 
postoperatively with the oxygen extraction ratio falling to 30% (Older and Smith, 1988, 
Older et al., 1993, Davies and Wilson, 2004). As stroke volume should be maximal 
postoperatively (Biccard, 2004) and haemoglobin should be optimally managed, the only 
two physiological determinants of increasing oxygen delivery are the heart rate response 
and the fraction of inspired oxygen. Thus patients able to increase their heart rate, are at a 
physiological advantage postoperatively over patients who are reliant on increasing 
peripheral oxygen uptake during increasing exercise. 
This prognostic marker has not been previously described. It suggests an 'aerobic surgical 
metabolic reserve' identifiable in potential survivors with a low AT. However, in order to 
confirm a statistically significant difference in the oxygen pulse and heart rate response 
between survivors and non-survivors, a sample size of 24 patients (12 patients per group) 
and 28 patients (14 patients per group) respectively would be required. This is based on the 
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results shown in Table 5.8 and calculated for a power of 80% and an alpha error of 5% 
(EpiCalc 2000, Joe Gilman and Mark Myatt 1998, Brixton Books). 
If one was to use the oxygen pulse response to increasing exercise intensity between 5 and 
7 ml.kg"1.min"1 to further discriminate patients, the sensitivity and specificity of the test 
would be further improved. A negative test result could be considered a 'high' AT or a 
'low' AT with an oxygen pulse increase of < 20% between 5 and 7 ml.kg^.min"1, and a 
positive test result could be considered a 'low' AT with an oxygen pulse increase of > 20% 
between 5 and 7 ml.kg"1.min"1. Using 20% as a cut-off is based on a 2SD from the mean of 
the change oxygen pulse in the survivors (mean + 1SD for survivors of 11.5% + 4.2). 
Table 6.1. The effect of incorporating oxygen pulse into the test result for CPET 
• m • IWII mSwini Tt in iSl i i i i i i » timrr urn i i i rm i — rm—i— v •• 
Anaerobic threshold and Cardiac deaths Survivors Total 
change in oxygen pulse 
Low with increase in oxygen 2 (100%) 0 2 
pulse >20% 
High or Low with increase in 6(11 %) 42 48 
oxygen pulse < 20% 
Fisher's Exact Test 2-tailed p=0.02. 
The risk ratio associated with cardiac death following a low AT coupled with an increase 
in oxygen pulse of >20% between 5 and 7 ml.kg"1.min"1 was 8.00 [95% CI 3.8-16.9]. The 
sensitivity was 0.25 [95% CI 0.04-0.64], the specificity was 1.00 [95% CI 0.90-1.00], the 
positive predictive value was 1.00 [95% CI 0.20-0.95] and the negative predictive value 
was 0.88 [95% CI 0.74-0.95]. The positive likelihood ratio is QO and the negative likelihood 
ratio is 0.75. 
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6.2.2. The presence of early myocardial ischaemia 
It is impossible to statistically evaluate early myocardial ischaemia as a clinical risk factor. 
As our patients were vascular surgical patients, the finding of early myocardial ischaemia 
on unloaded exercise may be an important prognosticator of significant coronary artery 
disease independent of the AT, in the presence of major vascular surgery. This is contrary 
to the case mix of major abdominal surgery as presented by Older's group where patients 
with a good anaerobic threshold and early myocardial ischaemia had a cardiovascular 
mortality of 4% with a low anaerobic threshold and early myocardial ischaemia had a 
cardiovascular mortality of 42% (Older et al., 1993). It therefore appears that medical 
therapy may be even inadequate in patients with a good AT, and I would recommend that 
all vascular surgical patients with early myocardial ischaemia on CPET, should be referred 
for coronary angiography. 
6.3. Clinical risk indices 
Lee's RCRI is the most predictive clinical risk index for major cardiac complications 
following surgery (Lee et al., 1999). However, when using a discriminator of less than 2 
clinical risk factors (which theoretically should be associated with a good clinical outcome) 
with acute peri-operative beta-blockade alone (Boersma et al., 2001), and more than 2 
clinical risk factors (a high risk group), no difference could be shown in the low risk and 
high risk group. There are two possible reasons for this. Firstly, the sample size is too 
small to show a difference. The second possibility is that the weighting of clinical risk 
factors for peri-operative cardiac events in our population (Steyn et al., 2005) is different to 
that reported in the international literature. It is important to continue to attempt to identify 
low-risk patients based on the presence or absence of clinical risk factors. This would 
54 
prevent inappropriate use of CPET (Grimes and Schulz, 2005), with resultant false positive 
test results and consumption of resources. 
6.4. Medical therapy 
It is likely that chronic beta-blockade may not be protective in the peri-operative period 
(Giles et al., 2004), as opposed to acute peri-operative beta-blockade (Devereaux et al., 
2005a). Conversely, statin therapy may provide peri-operative cardioprotection for high-
risk patients presenting for noncardiac surgery (Biccard et al., 2005b). Although neither 
drug was statistical associated with a specific cardiac outcome, the trends seen with 
chronic beta-blockade were consistent with the literature; there were more cardiac deaths 
in the chronically beta-blocked group (37% versus 11%). The real concern is despite the 
exceptionally high cardiac mortality in our patients, only 22% of these patients were on 
statin therapy prior to surgery. This is similar to what the incidence was between 1991 and 
2001 in Holland (Kertai et al., 2004). It is suggested that all vascular patients should 
receive statin therapy (MRC/BHF, 2002), and clearly the high mortality in this group 
suggests that this is appropriate, especially as statins positively affect the outcomes 
associated with acute coronary events (Biccard et al., 2005b). In the NCEPOD study of 
abdominal aneurysm surgery in the United Kingdom conducted over a two month period in 
2004, the incidence of statin therapy in elective patients was 53% (NCEPOD, 2005). Thus 
our figures are approximately a quarter of the desirable therapeutic intervention 




CPET has been shown to be the only special investigation to provide valuable prognostic 
information in high-risk vascular patients in this study. It is for this reason that it is 
imperative that CPET continues in Durban. 
We now have pretest probabilities (Grimes and Schulz, 2005) associated with 
cardiovascular mortality and CPET. With continued auditing of our management and 
outcomes, we can apply likelihood ratios to our own work and with the use of Fagan's 
nomogram (Fagan, 1975) accurately prognosticate for both patient and surgeon. 
6.5.1. Future study recommendations 
There are three areas of research that should be immediately implemented. Firstly, the high 
cardiovascular mortality in these patients would suggest that there is a further subgroup in 
this population who sustain undiagnosed peri-operative myocardial infarctions. It is well-
known that postoperative myocardial infarctions increase adverse cardiac events twenty-
fold within two years of surgery (Mangano et al., 1992) and result in a fourfold increase in 
mortality within three to five years of surgery (Charlson et al., 1994). There is therefore a 
strong indication to study troponin levels in all the patients who are being referred for 
CPET to identify the incidence of myocardial infarction in this group, identify and manage 
peri-operative myocardial infarctions appropriately (which are currently been missed) and 
to identify those patients who are at increased long-term risk secondary to peri-operative 
myocardial infarction. 
Secondly, it is necessary to continue to study both the traditional clinical risk indices 
associated with postoperative cardiac complications (Lee et al., 1999), as well as follow 
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other clinical risk factors associated with AMI in Sub-Saharan Africans following the 
INTERHEART study (Steyn et al., 2005). It is vital that a clinical risk index is established 
which is specific for our patient population. 
Finally, the 'surgical heart rate reserve' needs to be clarified. Indeed, an appropriate 
approach would be to pool data from various centres currently performing CPET and 
analyse the findings. This would either confirm or refute the proposal made in this thesis. 
Similarly, the 'so-called' non-responders of haemodynamic optimisation studies may have 
thus been identified by the fact that they have a low 'surgical heart rate reserve'. 
6.5.2. Revision of the peri-operative management protocol of patients for elective 
abdominal or thoracic vascular surgery 
Based on the outcomes reported here, the following revised peri-operative management 
protocol of that listed in Table 2.12 is presented in Figure 6.1. The suggested revision of 
our peri-operative management protocol for elective major vascular surgery is based on the 
following principles. As the cardiovascular mortality of the group with a good AT without 
early myocardial ischaemia exceeds 10%, it is therefore appropriate to recommend that all 
these patients are acutely beta-blocked (Biccard et al., 2006), provided that there is no 
contra-indication. 
Some of the patients with a poor AT appear to still have the capacity to survive the surgical 
stress response. As it is likely that an adequate 'surgical heart rate reserve' is necessary to 
increase oxygen delivery postoperatively, should it be required (for example following 
acute haemorrhage or anaemia), beta-blockade cannot be recommended in these patients. 
However, as these patients are at major peri-operative cardiovascular risk they should all 
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receive peri-operative statin therapy (Biccard et al., 2005a) and be haemodynamically 
optimised (Kern and Shoemaker, 2002). Postoperatively, serial troponin levels should be 
monitored to identify if any of these patients are at risk of a late myocardial infarction 
secondary to myocardial oxygen-supply demand imbalance (Le Manach et al., 2005). If 
this is suggested, then late initiation of acute peri-operative beta-blockade may be 
considered once the stress response is starting to tail off. 
Cardiopulmonary exercise test 


























Figure 6.1. Flow diagram of proposed peri-operative management based on CPET 
result 
The patients without a 'surgical heart rate reserve' are unlikely to be able to tolerate any 
acute short-term increase in aerobic metabolic demand and hence oxygen delivery. In these 
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patients, conservative management or 'lesser' surgical procedures should be seriously 
considered. 
All patients experiencing early myocardial ischaemia on CPET, should be referred for 
coronary angiography to exclude patients with lesions warranting coronary 
revascularisation pre-operatively. This approach would not over-extend resources, as in a 
nearly two year period, this would have resulted in three patients been referred to 
cardiology for angiography. Indeed, it could be argued that the use of CPET pre-
operatively significantly decreases unnecessary cardiological referrals. 
Based on the angiographic result, two management options can be considered. In the 
patients with coronary artery disease warranting revascularisation, this should proceed 
prior to the noncardiac surgery. These patients should then return for a repeat CPET prior 
to the noncardiac surgery. Peri-operative management decisions should be determined by 
this second CPET. 
Patients referred for coronary angiography, who are found not to have an indication for 
coronary revascularisation should be managed with acute intense peri-operative beta-
blockade. As myocardial ischaemia is almost certainly present at the metabolic demand 
associated with the postoperative stress response, a lesser procedure with a commensurate 
lesser stress response would be preferable. 
6.6. Limitations of this work 
This work is retrospective. The sample size is small and hence a number of questions can 
not yet be answered. The clinicians were not blinded to the results. In addition, the AT cut-
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off for arm cranking was estimated. It has not been prospectively evaluated. As only two 
individuals died following arm cranking (one in the 'low' group and one in the 'high' 
group), it is impossible to assess the validity of 9 ml.kg"1.min"1 as a predictor of peri-
operative cardiac outcome. In this study, a cutoff value of 8.9 ml.kg" .min"1 performed best 
with a sensitivity of 50% and a specificity of 93%. A larger sample size is needed in order 
to further define an appropriate cutoff value for arm cranking. 
6.7 Conclusion 
Pre-operative CPET at IALCH for high-risk South African surgical patients provides 
clinically useful peri-operative prognostic information. The CPET result allows for 
appropriate patient risk stratification and peri-operative management. Further investigation 
is required to confirm the importance of a 'high oxygen extraction' between 5 and 7 
ml.kg"1.min"1 and 'early myocardial ischaemia' measured during CPET as determinants of 
patient survival. It is recommended that CPET continues as a clinical service for high-risk 
surgical patients at IALCH. 
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Appendices 
1. Letter of ethical approval 
24 February 2006 
Mr B Biccard 
Department of Physiology 
Nelson R Mandela School of Medicine 
University of KwaZulu-Natal 
PROTOCOL: CARDIOPULMONARY EXERCISE TESTING FOR HIGH RISK -
SOUTH AFRICAN SURGICAL PATIENTS. B BICCARD, PHYSIOLOGY. REF: 
H331/05 
Dear Mr Biccard 
A sub-committee of the Biomedical Research Ethics Committee considered the 
abovementioned application and the protocol was approved. The study is given full ethics 
approval and may begin as at today's date: 24 February 2006. 
This approval is valid for one year from 24 February 2006. To ensure continuous 
approval, an application for recertification should be submitted a couple of months before 
the expiry date. In addition, when consent is a requirement, the consent process will need 
to be repeated annually. 
I take this opportunity to wish you everything of the best with your study. Please send the 
Biomedical Research Ethics Committee a copy of your report once completed. 
Yours sincerely 
PROFESSOR J MOODLEY 
Chair: Biomedical Research Ethics Committee 
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2. Clinical risk factors 
a. Ischaemic heart disease- history 
b. Ischaemic heart disease- ECG 
c. History of congestive cardiac failure 
d. History of stroke 
e. Diabetes mellitus 
f. Serum creatinine 
g. Hypertension 
h. Left ventricular ejection fraction 
i. Chronic beta-blockade 
j . Statin therapy 
3. Cardiopulmonary exercise test 
a. Type of test 
b. Anaerobic threshold 
c. Presence and time of myocardial ischaemia during CPET 
d. Heart rate between 5 and 7 ml.kg"1 .min"1 
e. Oxygen pulse between 5 and 7 ml.kg" .min" 
4. Surgical procedure 
5. Postoperative outcome until discharge 
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a. Death 
b. Myocardial infarction 
c. Inotrope requirements 
d. Postoperative haemorrhage 
e. Postoperative anaemia 
f. Postoperative blood pressure 
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